Urinary and gastrointestinal systems medications.
This article reviews the medical management of the neurogenic bladder and bowel. The drugs discussed specifically affect detrusor instability, detrusor weakness, high urethral pressure, low urethral closure pressure, inflammatory cystitis, and chronic constipation.
Schryvers
O
O
Department of Internal Medicine, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Nance
P W
PW
D000322:Adrenergic Agonists / Q000627:therapeutic use*; D000818:Animals; D018679:Cholinergic Agonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000534:rehabilitation; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D014570:Urologic Diseases / Q000188:drug therapy* / Q000534:rehabilitation
D000322:Adrenergic Agonists; D018679:Cholinergic Agonists; D005765:Gastrointestinal Agents